$2.90 2.7%
ABOS Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Acumen Pharmaceuticals

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease.

Acumen Pharmaceuticals
Price $2.90
Target Price Sign up
Volume 762,340
Market Cap $169M
Year Range $1.86 - $4.64
Dividend Yield 0%
Revenue per Employee $777,647
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '243M5.3M-2.3M-15M-18M-0.250
Q4 '2310M5.2M5M-16M-18M-0.280
Q3 '2304.9M-4.9M-13M-16M-0.240
Q2 '2304.3M-4.3M-12M-13M-0.280
Q1 '231.8M4.4M-4.4M-11M-13M-0.280

Insider Transactions View All

Meisner Derek M filed to sell 108,867 shares at $3.5.
January 19 '24
OConnell Daniel Joseph filed to sell 502,485 shares at $3.5.
January 19 '24
Barton Russell filed to sell 96,867 shares at $3.7.
January 19 '24
Siemers Eric filed to sell 117,576 shares at $3.7.
January 19 '24
Zuga Matt filed to sell 211,445 shares at $3.7.
January 19 '24

What is the Market Cap of Acumen Pharmaceuticals?

The Market Cap of Acumen Pharmaceuticals is $169M.

How Many People Work at Acumen Pharmaceuticals?

As of our latest update, Acumen Pharmaceuticals employed approximately 17 people worldwide. However, it's important to note that Acumen Pharmaceuticals' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Acumen Pharmaceuticals' revenue per employee?

$777,647. To calculate Acumen Pharmaceuticals' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Acumen Pharmaceuticals?

Currently, the price of one share of Acumen Pharmaceuticals stock is $2.90.

How can I analyze the ABOS stock price chart for investment decisions?

The ABOS stock price chart above provides a comprehensive visual representation of Acumen Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Acumen Pharmaceuticals shares. Our platform offers an up-to-date ABOS stock price chart, along with technical data analysis and alternative data insights.

Does ABOS offer dividends to its shareholders?

As of our latest update, Acumen Pharmaceuticals (ABOS) does not offer dividends to its shareholders. Investors interested in Acumen Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Acumen Pharmaceuticals?

Some of the similar stocks of Acumen Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.